Cite
HARVARD Citation
Klettner, A. et al. (2015). Compatibility of recombinant tissue plasminogen activator (rtPA) and aflibercept or ranibizumab coapplied for neovascular age-related macular degeneration with submacular haemorrhage. British journal of ophthalmology. 99 (6), pp. 864-869. [Online].